NAPOLITANO, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 4.692
EU - Europa 3.509
AS - Asia 2.433
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 5
OC - Oceania 3
Totale 10.675
Nazione #
US - Stati Uniti d'America 4.674
CN - Cina 2.359
IE - Irlanda 1.108
UA - Ucraina 660
DE - Germania 361
FI - Finlandia 352
IT - Italia 350
SE - Svezia 332
GB - Regno Unito 163
FR - Francia 130
JP - Giappone 30
SG - Singapore 24
MU - Mauritius 20
CA - Canada 18
BE - Belgio 16
RU - Federazione Russa 15
IN - India 11
NL - Olanda 7
IR - Iran 6
EU - Europa 5
PT - Portogallo 4
ZA - Sudafrica 4
BR - Brasile 3
CZ - Repubblica Ceca 3
GR - Grecia 3
AU - Australia 2
CH - Svizzera 2
CL - Cile 2
ET - Etiopia 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
HU - Ungheria 1
LV - Lettonia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PL - Polonia 1
Totale 10.675
Città #
Dublin 1.108
Chandler 1.040
Jacksonville 854
Nanjing 699
Ashburn 357
Nanchang 301
Princeton 259
Lawrence 233
Wilmington 222
Hebei 219
Changsha 187
Shenyang 182
Beijing 164
Jiaxing 151
Medford 148
Boardman 130
Tianjin 116
Helsinki 103
Shanghai 101
Hangzhou 86
Woodbridge 82
Milan 73
San Genesio Ed Uniti 69
Ann Arbor 63
New York 56
Norwalk 47
Falls Church 45
Verona 41
Seattle 30
Des Moines 25
Pavia 25
Tokyo 24
Chicago 22
Houston 21
Fairfield 19
Kunming 19
Los Angeles 18
Singapore 17
Brussels 16
Zhengzhou 16
Jinan 14
Toronto 13
Washington 13
Ningbo 12
Tappahannock 11
Dearborn 10
Changchun 9
Palermo 9
Rome 9
Taizhou 9
Auburn Hills 7
Guangzhou 7
Orange 7
Pune 6
Somma Lombardo 6
Borås 5
Kobe 5
Lanzhou 5
Piscataway 5
Zola Predosa 5
Alghero 4
Redmond 4
Barreiro 3
Berlin 3
Brno 3
Como 3
Fuzhou 3
Genoa 3
Mountain View 3
Novara 3
Phoenix 3
Pozzuolo Martesana 3
Rockville 3
San Francisco 3
Ypsilanti 3
Addis Ababa 2
Andover 2
Bari 2
Bex 2
Bologna 2
Boves 2
Cremona 2
Dallas 2
Desio 2
Falkenstein 2
Forest City 2
Gavardo 2
Genova 2
Las Vegas 2
Montreal 2
Naples 2
Parma 2
Pesaro 2
Pittsburgh 2
Potsdam 2
Sassari 2
Sovizzo 2
Tabriz 2
West Jordan 2
Abbotsford 1
Totale 7.651
Nome #
Tachicardia Ventricolare Polimorfa Catecolaminergica 127
From decision to shared-decision: Introducing patients' preferences into clinical decision analysis. 119
Graphical Representation of Life Paths to Better Convey Results of Decision Models to Patients. 90
Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice 79
Patient-tailored Workflow Patterns from Clinical Practice Guidelines Recommendations. 77
Gene-specific therapy for inherited arrhythmogenic diseases 74
Computer simulation of wild-type and mutant human cardiac Na+ current 73
A method of gene transfer for the treatment of recessive CPVT 73
Risk stratification in the Long-QT Syndrome 72
A cardiac arrhythmia syndrome caused by loss of ankyrin-B function 69
Arrhythmogenic Right Ventricular Cardiomyopathy: Clinical Course and Predictors of Arrhythmic Risk 69
Abnormal Calcium Signalling and Sudden Cardiac Death Associated With Mutation of Calsequestrin. 68
FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. 68
Arrhythmogenic mechanisms in a mouse model of Catecholaminergic Polymorphic Ventricular Tachycardia. 68
Loss of function associated with novel mutations of the SCN5A gene in patients with Brugada syndrome 66
Inherited arrhythmia: present and future perspectives for genetic therapy 65
Sympathetic activation, ventricular repolarization and Ikr blockade: implications for the antifibrillatory efficacy of potassium channel blocking agents 65
Interplay between Clinical Guidelines and Organizational Workflow Systems. Experience from the MobiGuide project 65
Policy statement: ESC-ERC recommendations for the use of automated external defibrillators (AEDs) in Europe. 64
Supporting shared decision making within the MobiGuide project. 64
Cardiac Sodium Channel Diseases 63
A newly charactarized SCN5A mutation underlying Brugada Syndrome unmasked by Hyperthermia 63
Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. 62
Yield of Genetic Screening in Inherited Cardiac Channelopathies. 62
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 62
Assessment of a personalized and distributed patient guidance system 62
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 61
Molecular underpinning of ''good luck'' 61
Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome. 61
“Cardiac Risk Stratification by NOS1AP Genotyping” 60
The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases 60
Allele-Specific Silencing of Mutant mRNA Rescues Ultrastructural and Arrhythmic Phenotype in Mice Carriers of the R4496C Mutation in the Ryanodine Receptor Gene (RYR2). 60
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 60
Evaluation of BLS-D training in lay people. 59
Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. 59
R Engine Cell: integrating R into the i2b2 software infrastructure. 59
Increased Ca2+ Sensitivity of the Ryanodine Receptor Mutant RyR2R4496C Underlies Catecholaminergic Polymorphic Ventricular Tachycardia. 59
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 59
Information extraction from Italian medical reports: An ontology-driven approach 58
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 58
Genotype-Phenotype correlation in the Long QT Syndrome. Gene-specific triggers for life-threatening arrhythmias 57
Modulating effects of age and gender on the clinical course of long QT syndrome by genotype 57
L-TYPE CALCIUM CHANNEL DISEASE 57
Combining decision support system-generated recommendations with interactive guideline visualization for better informed decisions 57
Inherited arrhythmia syndromes: applying the molecular biology and genetic to the clinical management. 56
Molecular and electrophysiological bases of catecholaminergic polymorphic ventricular tachycardia. 56
Long QT Syndrome 56
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 56
Novel Arrhythmogenic mechanism revealed by Long-QT Syndrome mutation in the Cardiac NA+ Channel 56
Abnormal Interactions of Calsequestrin With the Ryanodine Receptor Calcium Release Channel Complex Linked to Exercise-Induced Sudden Cardiac Death 56
Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers 56
Timothy Syndrome 55
Gene-specific differences in the circadian variation of ventricular repolarization in the long QT syndrome: a key to sudden death during sleep? 55
Genetics of Arrhythmogenic Disorders 55
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 55
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 55
Role of genetic analyses in cardiology: part I: mendelian diseases: cardiac channelopathies 54
Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes 54
Impact of molecular biology on diagnosis and management of arrhythmogenic disordes. 54
Letter regarding article by Coronel et al, ''right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study'' 53
Na+-dependent SR Ca2+ overload induces arrhythmogenic events in mouse cardiomyocytes with a human CPVT mutation 53
Arrhythmogenesis in Catecholaminergic Polymorphic Ventricular Tachycardia: insights from a RyR2 R4496C knock-in mouse model 53
Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome. 53
Genetics of ion-channel disorders 53
Patient-tailored workflow patterns from clinical practice guidelines recommendations 53
MobiGuide: a personalized and patient-centric decision-support system and its evaluation in the atrial fibrillation and gestational diabetes domains 53
Programmed ventricular stimulation for risk stratification in the Brugada syndrome: A pooled analysis 53
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 53
Brugada syndrome 53
A Recessive Variant of the Romano-Ward Long QT Syndrome 52
The long QT syndrome 52
CARDIO-i2b2: integrating arrhythmogenic disease data in i2b2. 52
Abnormal Propagation of Calcium Waves and Ultrastructural Remodeling in Recessive Catecholaminergic Polymorphic Ventricular Tachycardia. 52
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 52
Big Data as a Driver for Clinical Decision Support Systems: A Learning Health Systems Perspective 52
Experimental Therapy of genetic arrhythmias: disease-specific pharmacology. 51
Concealed arrhythmogenic syndromes: the hidden substrate of idiopathic ventricular fibrillation? 51
BRUGADA SYNDROME AND CONDUCTION SYSTEM DISEASE ARE LINKED TO A SINGLE SODIUM CHANNEL MUTATION. 51
Genetics of Cardiovascular Diseases 51
When is genetic testing useful in patients suspected to have inherited cardiac arrhythmias? 51
Significance of QT Dispersion in the Long QT Syndrome 51
Viral Gene Transfer Rescues Arrhythmogenic Phenotype and Ultrastructural Abnormalities in Adult Calsequestrin-Null Mice With Inherited Arrhythmias 51
Evaluation of spatial aspects of T-wave complexity in the Long QT syndrome 51
Catecholaminergic Polymorphic Ventricular Tachycardia 51
Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age 51
Evaluation of QT dispersion in the clinical practice: a critical review 51
[Computerized tomography study of 32 patients with disk hernia confirmed during surgical intervention]. 51
In the RyR2R4496C Mouse Model of CPVT, {beta}-Adrenergic Stimulation Induces Ca Waves by Increasing SR Ca Content and Not by Decreasing the Threshold for Ca Waves. 50
Homozygous Deletion in KVLQT1 Associated With Jervell and Lange-Nielsen Syndrome. 50
Cardiac Ion Channel Diseases: Clinical Impact 50
RyRCa Leak Limits Cardiac Ca Windows Current Overcoming the Tonic Effect of Calmodulin Mice. 50
Sodium current disorders: Geneticist's view 50
Brugada Syndrome and Sudden Cardiac Death in Children. 49
Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism 49
Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C+/-) mice with catecholaminergic polymorphic ventricular tachycardia. 49
Genetic and molecular basis of arrhythmias. 49
The genetics of cardiomyopathy: genotyping and genetic counseling. 49
Long QT syndrome in adults. 49
Romano-Ward and other congenital long QT syndromes 48
Role of the autonomic nervous system in sudden death 48
Totale 5.874
Categoria #
all - tutte 41.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.032


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.720 871 1.124 3 120 5 132 8 149 8 189 108 3
2020/20211.307 144 125 44 123 2 175 10 186 77 196 171 54
2021/20221.003 8 2 16 6 27 55 34 59 82 51 155 508
2022/20233.090 363 193 42 260 289 350 2 146 1.298 18 78 51
2023/20241.169 137 175 55 103 107 315 53 63 5 24 36 96
2024/202545 45 0 0 0 0 0 0 0 0 0 0 0
Totale 10.836